Author:
Lee Steve C.,Ferris Robert L.
Reference113 articles.
1. Vlock DR, Schantz SP, Fisher SG, Savage HE, Carey TE, Wolf GT. Clinical correlates of circulating immune complexes and antibody reactivity in squamous cell carcinoma of the head and neck. The Department of Veterans Affairs Laryngeal Cancer Study Group. J Clin Oncol. 1993;11:2427–33.
2. Calenoff E, Cheever MA, Satam M, et al. Serum immunoglobulins specific for intracellular proteins of squamous cell carcinoma. Archives of otolaryngology. Head Neck Surg. 1995;121:183–91.
3. Couch ME, Ferris RL, Brennan JA, et al. Alteration of cellular and humoral immunity by mutant p53 protein and processed mutant peptide in head and neck cancer. Clin Cancer Res. 2007;13:7199–206.
4. Rabassa ME, Croce MV, Pereyra A, Segal-Eiras A. MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis. BMC Cancer. 2006;6:253.
5. Yamaguchi K, Patturajan M, Trink B, et al. Circulating antibodies to p40(AIS) in the sera of respiratory tract cancer patients. Int J Cancer. 2000;89:524–8.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biological Treatments (Antibodies);Head & Neck Cancer: Current Perspectives, Advances, and Challenges;2013